key: cord-0925098-mwbq4hy0
authors: Zhao, H; Yan, S; Zhang, F; Wright, J D; Hou, J Y; Cata, J P; Cai, X; Xiu, D; Mao, Y; Zhang, B; Du, S; Li, M; Zhang, H; Cai, J
title: Guidance for safely performing oncologic surgery during the COVID-19 pandemic
date: 2020-07-28
journal: Br J Surg
DOI: 10.1002/bjs.11845
sha: 481359e7dd54701f751d12f79a5a6b9727e903c9
doc_id: 925098
cord_uid: mwbq4hy0

nan

Patients are first screened with body temperature. Patients with fever will be referred to fever clinic for further investigation. Patients without fever will be triaged with COVID-19 related symptoms*, travel history and exposure to others with COVID-19. In the standardized protocol, CBC, CT of the chest and SARS-CoV-2 RT-PCR are universally tested. # SARS-CoV-2 RT-PCR testing is not included in the simplified protocol for regions with a low burden of COVID-19. COVID-19 antibody testing is optional since it is not widely available. Patients with negative results from all evaluations are admitted for observation in the isolation ward for three to seven days prior to their surgery. Only patients with no suspicious clinical manifestations during the observation will proceed to surgery. If a patient develops any symptoms that raise suspicion for COVID-19 infection during observation, further testing and investigation are initiated. Confirmed COVID-19 patients will be transferred to designated hospitals for treatment. (SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2; RT-PCR, Reverse Transcription Polymerase Chain Reaction).

found that COVID-19 antibody testing is highly specific for excluding COVID-19 disease. Of all the patients (n = 3652) who had initial negative antibody testing, none were positive with subsequent COVID-19 RT-PCR testing. Our data demonstrate that oncologic surgery can be performed safely during the COVID-19 pandemic after the implementation of a comprehensive and standardized preoperative screening protocol.

While we recognize that routine preoperative hospitalization may not be feasible everywhere, we believe the tenets of this protocol provide valuable insight and guidance to safely perform cancer-directed surgery in regions where COVID-19 is prevalent. COVID-19 RT-PCR testing has been recently applied to screen all surgical candidates in some institutions in the U.S. (Fig. 1) . Considering the false negative result of the COVID-19 RT-PCR testing, adding antibody testing can significantly minimize the overall false negative rate. Ongoing data collection will allow us to validate different approaches and optimize protocols. and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

Global guidance for surgical care during the COVID-19 pandemic

Are we harming cancer patients by delaying their cancer surgery during the COVID-19 pandemic?

Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)

Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases